# Neostigmine Methylsulfate

NDC: 70069-805
Generic name: Neostigmine Methylsulfate
Labeler / Manufacturer: Somerset Therapeutics, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20220110

FDA application: ANDA213074

## Active ingredients

- NEOSTIGMINE METHYLSULFATE: .5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70069-805"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70069-805
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ea767851-b0ab-4a4c-a4b2-680ff4086636